Physio Lecture 7 Introduction to Cardiovascular Physiology Prof

  • Slides: 51
Download presentation
Physio Lecture 7 – Introduction to Cardiovascular Physiology Prof. dr. Željko Dujić

Physio Lecture 7 – Introduction to Cardiovascular Physiology Prof. dr. Željko Dujić

MAIN FUNCTIONS OF THE CIRCULATORY SYSTEM -Transport and distribute essential substances to the tissues

MAIN FUNCTIONS OF THE CIRCULATORY SYSTEM -Transport and distribute essential substances to the tissues (most important to the vital organs – brain and heart). -Remove metabolic byproducts. -Adjustment of oxygen and nutrient supply in different physiologic states. -Regulation of body temperature. - Humoral communication by maintaining tissue perfusion.

Pressure Profile of the Circulatory System ELASTIC TISSUE MUSCLE

Pressure Profile of the Circulatory System ELASTIC TISSUE MUSCLE

THE SYSTEMIC CIRCULATION CAPACITY VESSELS

THE SYSTEMIC CIRCULATION CAPACITY VESSELS

Distribution of Blood in the Circulatory System

Distribution of Blood in the Circulatory System

PULMONARY CIRCULATION 1. LOW RESISTANCE 2. LOW PRESSURE (25/10 mm. Hg) SYSTEMIC CIRCULATION 1.

PULMONARY CIRCULATION 1. LOW RESISTANCE 2. LOW PRESSURE (25/10 mm. Hg) SYSTEMIC CIRCULATION 1. HIGH RESISTANCE 2. HIGH PRESSURE (120/80 mm. Hg) PARALLEL SUBCIRCUITS UNIDIRECTIONAL FLOW

ARTERIES (LOW COMPLIANCE) HEART DIASTOLE VEINS CAPACITY VESSELS 80 mm. Hg 120 mm. Hg

ARTERIES (LOW COMPLIANCE) HEART DIASTOLE VEINS CAPACITY VESSELS 80 mm. Hg 120 mm. Hg SYSTOLE CAPILLARIES

Membrane potential and critical equations EK = -60 LOG ([Ki]/[Ko]) = -94 mv ENa

Membrane potential and critical equations EK = -60 LOG ([Ki]/[Ko]) = -94 mv ENa = -60 LOG ([Nai]/[Nao]) = +70 mv Em = RT/F ln PK (K+)o + PNa(Na+)o + PCl(Cl-)i PK (K+)I + PNa(Na+)i + PCl(Cl-)o

CARDIAC ELECTROPHYSIOLOGY UPDATE EXTRA CELL. INTRACELL. Em Na+ 145 Mm 15 Mm 70 m.

CARDIAC ELECTROPHYSIOLOGY UPDATE EXTRA CELL. INTRACELL. Em Na+ 145 Mm 15 Mm 70 m. V Ca++ 3 Mm 10 -7 M 132 m. V K+ 5 Mm 145 Mm -100 m. V

Action potentials from different heart areas ATRIUM VENTRICLE 0 mv mv 0 -80 mv

Action potentials from different heart areas ATRIUM VENTRICLE 0 mv mv 0 -80 mv SA NODE mv 0 -80 mv time

MEMBRANE POTENTIAL (m. V) 0 PHASE 0 = Rapid Depolarization Mechanical Response (inward Na+

MEMBRANE POTENTIAL (m. V) 0 PHASE 0 = Rapid Depolarization Mechanical Response (inward Na+ current) 1 1 = Overshoot 2 2 = Plateau (inward Ca++ current) 3 = Repolarization + current) (outward K 0 4 = Resting Potential 3 4 -90 TIME

K+ CURRENTS AND REPOLARIZATION • Phase 1 - transient outward current (TOC) Ito •

K+ CURRENTS AND REPOLARIZATION • Phase 1 - transient outward current (TOC) Ito • Phase 1 -3 - delayed rectifier current IK • Phase 1 -4 – inwardly rectifier current IKl

THE PLATEAU PHASE AND CALCIUM IONS OPEN CLINICAL VALUE L Ca++ CHANNELS +10 m.

THE PLATEAU PHASE AND CALCIUM IONS OPEN CLINICAL VALUE L Ca++ CHANNELS +10 m. V Ca++ BLOCKERS T Ca++ CHANNELS -20 m. V NO (physiological)

OVERVIEW OF SPECIFIC EVENTS IN THE VENTRICULAR CELL ACTION POTENTIAL

OVERVIEW OF SPECIFIC EVENTS IN THE VENTRICULAR CELL ACTION POTENTIAL

Overview of Important Channels in Cardiac Electrophysiology Sodium Channels Fast Na+ Phase 0 depolarization

Overview of Important Channels in Cardiac Electrophysiology Sodium Channels Fast Na+ Phase 0 depolarization of non-pacemaker cardiac action potentials Slow Na+ "Funny" pacemaker current (If) in cardiac nodal tissue Potassium Channels Inward rectifier (Iir or Maintains phase 4 negative potential in cardiac cells IK 1) Transient outward (Ito) Contributes to phase 1 of non-pacemaker cardiac action potentials Delayed rectifier (IKr) Phase 3 repolarization of cardiac action potentials

Cont’ed with Channels Calcium Channels L-type (ICa. L) Slow inward, long-lasting current; phase 2

Cont’ed with Channels Calcium Channels L-type (ICa. L) Slow inward, long-lasting current; phase 2 non-pacemaker cardiac action potentials and phases 4 and 0 of SA and AV nodal cells; important in vascular smooth muscle contraction T-type (ICa. T) Transient current that contributes to phase 4 pacemaker currents in SA and AV nodal cells

ELECTROPHYSIOLOGY OF THE SLOW RESPONSE FIBER 0 m. V 2 0 -40 -80 3

ELECTROPHYSIOLOGY OF THE SLOW RESPONSE FIBER 0 m. V 2 0 -40 -80 3 ARP 4 RRP time (msec) RECALL: INWARD Ca++ CURRENT CAUSES DEPOLARIZATION

CONDUCTION OF THE ACTION POTENTIAL IN CARDIAC FIBERS LOCAL CURRENTS - ------+++++++ - --

CONDUCTION OF THE ACTION POTENTIAL IN CARDIAC FIBERS LOCAL CURRENTS - ------+++++++ - -- - - FIBER A FIBER B DEPOLARIZED ZONE

CONDUCTION OF THE ACTION POTENTIAL • FAST RESPONSE: Depends on AP Amplitude, Rate of

CONDUCTION OF THE ACTION POTENTIAL • FAST RESPONSE: Depends on AP Amplitude, Rate of Potential Change, level of Em. • SLOW RESPONSE: Slower conduction. More apt to conduction blocks. • WHAT ABOUT MYOCARDIAL INFARCTS AND CONDUCTION?

AFTER THE EFFECTIVE OR ABSOLUTE REFRACTORY PERIOD (FAST FIBER) 0 MV ARP -80 RRP

AFTER THE EFFECTIVE OR ABSOLUTE REFRACTORY PERIOD (FAST FIBER) 0 MV ARP -80 RRP TIME

POST-REPOLARIZATION REFRACTORINESS (SLOW FIBER) 200 MSEC 0 m. V B A -60 POSTREPO TIME

POST-REPOLARIZATION REFRACTORINESS (SLOW FIBER) 200 MSEC 0 m. V B A -60 POSTREPO TIME C

 CHARACTERISTICS OF THE PACEMAKER POTENTIAL PHASE 4 -PACEMAKER POTENTIAL(PP). FREQUENCY DEPENDS ON: THRESHOLD,

CHARACTERISTICS OF THE PACEMAKER POTENTIAL PHASE 4 -PACEMAKER POTENTIAL(PP). FREQUENCY DEPENDS ON: THRESHOLD, RESTING POTENTIALS AND SLOPE OF THE PP

THE CONDUCTION SYSTEM OF THE HEART

THE CONDUCTION SYSTEM OF THE HEART

PACEMAKERS (in order of their inherent rhythm) • • • Sino-atrial (SA) node (HR

PACEMAKERS (in order of their inherent rhythm) • • • Sino-atrial (SA) node (HR 60 -70) Atrio-ventricular (AV) node (HR 40) Bundle of His (HR 15 -40) Bundle branches Purkinje fibers

CARDIAC MECHANICS MAIN THEMES THE HEART AS A PUMP THE CARDIAC CYCLE CARDIAC OUTPUT

CARDIAC MECHANICS MAIN THEMES THE HEART AS A PUMP THE CARDIAC CYCLE CARDIAC OUTPUT

THE HEART AS A PUMP • REGULATION OF CARDIAC OUTPUT – Heart Rate via

THE HEART AS A PUMP • REGULATION OF CARDIAC OUTPUT – Heart Rate via sympathetic & parasympathetic nerves – Stroke Volume • Frank-Starling “Law of the Heart” • Changes in Contractility • MYOCARDIAL CELLS (FIBERS) – Regulation of Contractility – Length-Tension and Volume-Pressure Curves – The Cardiac Function Curve

LEFT VENTRICULAR PRESSURE LENGHT/ TENSION AND THE FRANKSTARLING RELATION Systole Diastole INITIAL MYOCARDIAL FIBER

LEFT VENTRICULAR PRESSURE LENGHT/ TENSION AND THE FRANKSTARLING RELATION Systole Diastole INITIAL MYOCARDIAL FIBER LENGHT LEFT VENTRICULAR END-DIASTOLIC VOLUME

 • • PRELOAD AND AFTERLOAD IN THE HEART INCREASE IN FILLING PRESSURE=INCREASED PRELOAD

• • PRELOAD AND AFTERLOAD IN THE HEART INCREASE IN FILLING PRESSURE=INCREASED PRELOAD REFERS TO END DIASTOLIC VOLUME. AFTERLOAD IS THE AORTIC PRESSURE DURING THE EJECTION PERIOD/AORTIC VALVE OPENING. LAPLACES’S LAW & WALL STRESS, WS = P X R / 2(wall thickness)

CONTRACTILITY: THE VENTRICULAR FUNCTION CURVE EFFECT? CHANGES IN CONTRACTILITY

CONTRACTILITY: THE VENTRICULAR FUNCTION CURVE EFFECT? CHANGES IN CONTRACTILITY

CARDIAC FUNCTION CURVE 15 - 10 Pressure CARDIAC OUTPUT (L/min) THE FRANK- STARLING “LAW

CARDIAC FUNCTION CURVE 15 - 10 Pressure CARDIAC OUTPUT (L/min) THE FRANK- STARLING “LAW OF THE HEART” 5 - Volume -4 0 +4 RAP mm. Hg +8

CARDIAC FUNCTION CURVE CARDIAC OUTPUT (L/min) THE FRANK- STARLING “LAW OF THE HEART” 15

CARDIAC FUNCTION CURVE CARDIAC OUTPUT (L/min) THE FRANK- STARLING “LAW OF THE HEART” 15 - Inc Co rease ntr d act ilit y 10 - 5 - -4 0 +4 RAP mm. Hg +8

CARDIAC FUNCTION CURVE CARDIAC OUTPUT (L/min) THE FRANK- STARLING “LAW OF THE HEART” 15

CARDIAC FUNCTION CURVE CARDIAC OUTPUT (L/min) THE FRANK- STARLING “LAW OF THE HEART” 15 - De c Co reas ntr ed act ilit y 10 - 5 - -4 0 +4 RAP mm. Hg +8

EJECTION PRESSURE (mm. Hg) ISOVOLUMETRIC RELAXATION RAPID INFLOW ISOVOLUMETRIC DIASTASIS CONTRACTION ATRIAL SYSTOLE AORTIC

EJECTION PRESSURE (mm. Hg) ISOVOLUMETRIC RELAXATION RAPID INFLOW ISOVOLUMETRIC DIASTASIS CONTRACTION ATRIAL SYSTOLE AORTIC PRESSURE ATRIAL PRESSURE VOLUME (ml) VENTRICLE PRESSURE ECG PHONOCARDIOGAM SYSTOLE DIASTOLE SYSTOLE

HEART - BLOOD VESSELS COUPLING AT REST PUMP VEINS ARTERIES Qh CPV=2 mm. Hg=Pv

HEART - BLOOD VESSELS COUPLING AT REST PUMP VEINS ARTERIES Qh CPV=2 mm. Hg=Pv 5 L/min COMPLIANCES Cv = 19 Ca Cv>>>>Ca Qr PERIPHERAL R= Pa - Pv / Qr R = 20 mm. Hg/L/min 5 L/min Pa MPA=102 mm. Hg

CARDIAC ARREST! INMEDIATE EFFECT FLOW STOPS HERE PUMP VEINS ARTERIES Qh 0 L/min Pa

CARDIAC ARREST! INMEDIATE EFFECT FLOW STOPS HERE PUMP VEINS ARTERIES Qh 0 L/min Pa CPV=2 mm. Hg=Pv 5 L/min FLOW CONTINUES HERE TRANSFER ART-->VEINS Qr R = 20 mm. Hg/L/min Qr= Pa - Pv/20 Qr CONTINUES AS LONG AS A PRESSURE GRADIENT IS SUSTAINED

CARDIAC ARREST STEADY STATE FLOW STOPPED PUMP VEINS ARTERIES Qh 0 L/min Pa =

CARDIAC ARREST STEADY STATE FLOW STOPPED PUMP VEINS ARTERIES Qh 0 L/min Pa = 7 mm. Hg Pv = 7 mm. Hg = MEAN CIRCULATORY PRESSURE OR Pmc 5 mm. Hg FLOW STOPPED 0 L/min Qr Qr = 0 ( NO Pa - Pv DIFFERENCE) 95 mm. Hg

WE START PUMPING! INMEDIATE EFFECT FLOW STARTS SOME VENOUS BLOOD PUMP VEINS ARTERIES Qh

WE START PUMPING! INMEDIATE EFFECT FLOW STARTS SOME VENOUS BLOOD PUMP VEINS ARTERIES Qh 1 L/min Pa = 7 mm. Hg Pv = 7 mm. Hg NO FLOW HERE YET 0 L/min Qr

FLOW RETURNS AT Qr AT THE NEW Qh PUMP VEINS ARTERIES Qh 1 L/min

FLOW RETURNS AT Qr AT THE NEW Qh PUMP VEINS ARTERIES Qh 1 L/min Pa = 26 mm. Hg Pv = 6 mm. Hg FLOW STARTS 1 L/min Qr R = 20 mm. Hg Qr = Pa - Pv / 20 = 1 L/min

HEMODYNAMICS • • • VELOCITY, FLOW, PRESSURE LAMINAR FLOW POISEUILLE’S LAW RESISTANCE (SERIES-PARALLEL) TURBULENT

HEMODYNAMICS • • • VELOCITY, FLOW, PRESSURE LAMINAR FLOW POISEUILLE’S LAW RESISTANCE (SERIES-PARALLEL) TURBULENT FLOW AND REYNOLD’S NUMBER

REQUIRED CONCEPTS VELOCITY = DISTANCE / TIME V = D / T FLOW =

REQUIRED CONCEPTS VELOCITY = DISTANCE / TIME V = D / T FLOW = VOLUME / TIME Q = VL / T VELOCITY =FLOW/ AREA V = Q / A

CROSS SECTIONAL AREA AND VELOCITY A= 2 cm 2 10 cm 2 1 cm

CROSS SECTIONAL AREA AND VELOCITY A= 2 cm 2 10 cm 2 1 cm 2 Q=10 ml/s a b c V= 5 cm/s 1 cm/s 10 cm/s V = Q / A

POISEUILLE’S LAW GOVERNING FLUID FLOW(Q) THROUGH CYLINDRIC TUBES (FLOW)Q = (FLOW)Q DIFFERENCE IN PRESSURE

POISEUILLE’S LAW GOVERNING FLUID FLOW(Q) THROUGH CYLINDRIC TUBES (FLOW)Q = (FLOW)Q DIFFERENCE IN PRESSURE 4 (Pi - Po) r 8 n. L VISCOSITY LENGHT RADIUS

LAMINAR VS TURBULENT FLOW THE REYNOLD’S NUMBER LAMINAR FLOW TURBULENT FLOW Nr = p.

LAMINAR VS TURBULENT FLOW THE REYNOLD’S NUMBER LAMINAR FLOW TURBULENT FLOW Nr = p. Dv / n laminar = 2000 or less p = density D = diameter v = velocity n = viscosity

* The peak left coronary flow occurs at the end of isovolumetric relaxation *

* The peak left coronary flow occurs at the end of isovolumetric relaxation * Left coronary blood flow Right coronary blood flow

 Cessation of Myocardial Blood Flow mitochondria cytosol anaerobic glycolysis cellular p. O 2

Cessation of Myocardial Blood Flow mitochondria cytosol anaerobic glycolysis cellular p. O 2 < 5 mm. Hg within glycogen seconds glucose-6 -phosphate pyruvate oxidative phosphorylation lactate stops cellular acidosis depletion of ATP

Blood Vessel • Intima primarily the endothelial lining • Media vascular smooth muscle, collagen,

Blood Vessel • Intima primarily the endothelial lining • Media vascular smooth muscle, collagen, elastin • Adventitia connective tissue

Vascular Endothelium Vasodilators Vasoconstrictors Nitric Oxide Prostacyclin Endothelium-derived hyperpolarizing factor Bradykinin Endothelin-1 Angiotensin II

Vascular Endothelium Vasodilators Vasoconstrictors Nitric Oxide Prostacyclin Endothelium-derived hyperpolarizing factor Bradykinin Endothelin-1 Angiotensin II Wilson SH, Lerman A. Heart Physiology and Pathophysiology, Academic Pre (edited by Sperelakis N. ) 473 -480

L-Arginine is converted to NO by the enzyme nitric oxide synthase (NOS)

L-Arginine is converted to NO by the enzyme nitric oxide synthase (NOS)

Nitric Oxide (NO) Function • Vasodilator • Inhibitor of vascular smooth muscle cell proliferation

Nitric Oxide (NO) Function • Vasodilator • Inhibitor of vascular smooth muscle cell proliferation • Inhibitor of platelet adherence/aggregation • Inhibitor of leukocyte/endothelial interactions

Endothelin-1 (ET-1) • Peptide first sequenced in 1988 • Most potent vasoconstrictor in humans

Endothelin-1 (ET-1) • Peptide first sequenced in 1988 • Most potent vasoconstrictor in humans • Maintenance of basal arterial vasomotor tone • Strong chemoattractant for circulating monocytes and macrophage activation “proatherogenic”

Endothelial Dysfunction • Imbalance of endothelium-derived relaxing and contracting factors Atherosclerotic risk factors Decreased

Endothelial Dysfunction • Imbalance of endothelium-derived relaxing and contracting factors Atherosclerotic risk factors Decreased NO bioavailability Increased levels of ET-1